Tuberculosis is a leading pathogen worldwide, infecting an estimated 8 million and killing 2-3 million people each year (1) . Furthermore, it is estimated that approximately 2 billion people have been exposed to Mycobacterium tuberculosis and thus are at risk of developing the active disease. Although most of the infected individuals reside in less industrialized countries, the rates of infection in areas undergoing rapid social change, such as the Soviet Union, are also increasing at an alarming rate (2) . In part because of the symbiotic relationship between HIV and tuberculosis, and the increasingly rapid displacement of populations, the incidence of multidrug-resistant tuberculosis is an important worldwide concern. Thus, in a recent survey of 35 countries, 12.6% of M. tuberculosis isolates were found to be resistant to at least one drug, and 2.2% were resistant to both isoniazid and rifampin, the two primary drugs used to treat tuberculosis (3) . This resurgence of tuberculosis has led to renewed efforts to find new drugs for the treatment of this dread disease, particularly agents that exhibit activity against drug resistant strains, completely sterilize the infection, or shorten the duration of drug therapy and thus promote drug compliance.
One of the primary drugs used to treat tuberculosis is isoniazid, a prodrug that is oxidized by the KatG catalase-peroxidase to an activated form that inhibits cell wall synthesis (4, 5) . Isoniazid resistance commonly results from mutation of the KatG to a protein that is either inactive or has an impaired ability to activate isoniazid (6) (7) (8) (9) . The physiological function of the KatG catalase/peroxidase has not been completely defined, but includes protection of the mycobacterium against H2O2 and other reactive oxygen species produced by the microbe and its host (10, 11) . The attenuated virulence of KatG null strains of M. tuberculosis has been definitively established by experiments in which resistance to H2O2, and virulence, are restored by transfection with plasmid-encoded KatG (12) (13) (14) (15) . A conundrum therefore exists, in that loss or attenuation of KatG activity -an activity important for virulence -is required for resistance to isoniazid.
A possible solution to this conundrum is offered by the finding that suppression of KatG activity is paralleled by increased expression of the alkylhydroperoxidase AhpC (4, 11, (16) (17) (18) . AhpC is a member of the wide-spread non-heme peroxiredoxin family that catalyzes the reduction of alkylhydroperoxides to alcohols (19) , although additional functions have been ascribed to individual members of this protein family. For example, human peroxiredoxins, in addition to their alkylhydroperoxidase activity, have phospholipase A2 activity (20) and regulate NF-κB activation (21) . In microorganisms, the ahpC gene is usually under control of the oxyR locus, but this locus in M. tuberculosis is not functional (22, 23) . Enhanced expression of AhpC in M. tuberculosis involves elevated expression of the protein due to mutations in its promoter region (11, 17) . The M. tuberculosis AhpC has been expressed, purified, and shown to have peroxidase activity towards a broad range of substrates (24) . This activity was measured using either dithiothreitol or the Salmonella typhimurium AhpF flavoprotein as a surrogate electron donor because the native electron donor partner in M. tuberculosis has not been identified.
The genes for a number of flavoproteins of unknown function are present in M.
tuberculosis, but none of them correspond to the S. typhimurium ahpF gene (25) . The position immediately downstream of ahpC in the S. typhimurium genome is occupied by ahpF, but in the M. tuberculosis genome this position is taken by a gene termed ahpD because of its position relative to ahpC rather than because of any sequence or functional evidence.
Homologous ahpD genes have so far been found in a few other organisms, including other mycobacteria, Streptomyces viridosporus (26) , Streptomyces coelicolor (27) , Brucella melitensis (28) , and Ralstonia solanacearum (29) . We recently expressed the M. tuberculosis AhpD and demonstrated that, despite the absence of any sequence identity between AhpD and the AhpC family of proteins, it also exhibits alkylhydroperoxidase activity with the same surrogate electron transfer partners as utilized by AhpC (24) . The specific role of AhpD in detoxifying peroxides and other reactive oxygen and nitrogen species, and any possible additional functions of the protein, remain undetermined. Unlike ahpC, ahpD appears not to have been among the genes examined in microarray studies of changes in M. tuberculosis gene expression caused by drugs and hypoxia (18, 30) . However, its position relative to ahpC suggests that AhpD expression may be enhanced under the same conditions that enhance AhpC expression.
The ahpD (Rv2429) gene encodes a protein of 177 amino acids and a molecular mass of 18,781 Da (31). Size exclusion chromatography of the protein expressed in Escherichia coli indicates that AhpD is present as an oligomeric, possibly dimeric, species (24) . The AhpD sequence reveals the presence of two cysteines (Cys129 and Cys132, or Cys130 and Cys 133 if the initial methionine that is absent in the heterologously expressed protein is counted). The two cysteines are separated by a serine and a histidine. Site-specific mutagenesis of the cysteines has shown that both, but particularly Cys133, are important for 6 by guest on http://www.jbc.org/ Downloaded from alkylhydroperoxidase activity. We report here crystallization of M. tuberculosis AhpD and determination of its crystal structure to a resolution of 1.9 Å. The crystal structure reveals a homotrimeric protein in which each of the subunits has an identical but novel protein fold.
The structure suggests a mechanism for the alkylhydroperoxidase activity of AhpD.
Materials and Methods
Materials -M. tuberculosis AhpD was heterologously expressed in E. coli and purified as previously reported (24) . All chemical reagents were purchased from Sigma (St. Louis, MO). E. coli strain DL41, auxotrophic in methionine biosynthesis due to a metA disruption (32) , was obtained from the Yale University E. coli Genetic Stock Center (CGSC) (7CN).
Selenomethionine was from Acros. Trisodium citrate was from Aldrich (St. Louis, MO). LB and agar were from Difco. Acetic acid, chloramphenicol, NaCl, NaOH, SDS, and MOPS were from Fisher. Protein molecular weight standards were from Gibco BRL (Gaithersburg, MD). Thymine, guanosine, and adenine hemisulfate dihydrate were from ICN Biomedical (Aurora, OH). Purified proteins were concentrated using Millipore YM10 regenerated cellulose ultrafiltration membranes. Q-Sepharose was from Pharmacia (Peapack, NJ). IPTG was from Promega (Madison, WI). SC-Met was from Qbiogene (Carlsbad, CA). The selenomethionine labeled protein was purified according to the protocol of Hillas et al. (24) , except that 5 mM dithiothreitol and 0.2 mM EDTA were added to all the buffers and all the buffers used in protein purification were degassed. The degassing, EDTA and high concentration of dithiothreitol were employed to minimize the oxidation of selenomethionine to the selenoxide (33) . The buffers were degassed by subjecting them, with stirring, to a minimum of three 15-min cycles of house-line vacuum followed by 2 min of bubbling with nitrogen using a bubbler with a fine frit to optimize mixing of the gas into the buffer. In the case of buffers to be applied to chromatography columns, the final cycle should be done sufficiently in advance to allow dispersion of the gas bubbles, as this prevents the introduction of bubbles into the column.
Per 1 g of cells was added 5 ml of buffer B (50 mM potassium phosphate, pH 7.0, 5% glycerol, 0.2 mM EDTA, and 5 mM dithiothreitol) plus 0.5 mg/ml lysozyme, 44 µg/ml phenylmethylsulfonyl fluoride (PMSF), 2 µg/ml leupeptin, and 2 µg/ml pepstatin. The suspended cells were incubated on ice for 60 min and then, still on ice, were sonicated with a Branson sonifier 1/2" tip on setting 3 (~20 W output) for 4 cycles of alternating 30 sec continuous pulse followed by 30 sec of rest. To the supernatant obtained by ultracentrifugation for 30 min at 100,000 x g (4 o C) was added polyethyleneimine to a concentration of 0.005%. The mixture was incubated on ice for 15 min to precipitate the nucleic acids, and the mixture was then centrifuged as above to produce the crude lysate supernatant.
The crude lysate was loaded onto a 2.5 cm x 17 cm (~ 80 ml) Q-Sepharose column at 1 ml/min. The column was washed with 10-20 column volumes of buffer B at 1 ml/min, and the protein was then eluted at 1 ml/min using a linear gradient of 375 ml buffer B and 375 ml buffer B containing 100 mM KCl. Fractions of 7.5 ml resulted in elution of the AhpD protein in fractions 1-45. Every other fraction from 1-43 was analyzed via SDS-PAGE. Pure fractions were pooled and concentrated to 20 mg/ml or greater using a Millipore concentrator equipped with a YM10 (10,000 molecular weight cutoff) regenerated cellulose ultrafiltration membrane. The concentration was determined using a molar extinction coefficient of 15,720 M -1 cm -1 (5CN). For volumes of 0.5 to 3.0 ml, the concentrated solution was loaded into a Pierce Slide-A-Lyzer cassette and dialyzed three times against 1 L of 50 mM MOPS, pH 7.2, 100 mM KCl, 20% glycerol, 5 mM dithiothreitol, and 0.2 mM EDTA. The protein was then aliquoted into 25 µl or 100 µl volumes, frozen on dry ice, and stored until used at 80 o C.
The protein was subjected to analysis on 20% homogeneous gels using the PhastSystem (Pharmacia). The protein molecular weight standards (Gibco) were prestained insulin (α and β chains, usually unresolvable), bovine trypsin inhibitor, lysozyme, β-lactoglobulin, Table 1 .
Multi-wavelength phasing, model building and refinement -Within the smaller C2 cell a protein trimer exists within the crystallographic asymmetric unit. Selenium sites were located from Patterson search procedures using the program CNS (36) . Six selenium sites were located with two Se sites in each AhpD protein, at positions 78 and 80 of the protein sequence. After density modification in CNS (36) initial chain tracing was carried out using the program TURBO-FRODO (37) . ARP/wARP (38) was run in parallel and located some of the α-helical regions of the structure (approximately one third of the structure located using ARP/wARP). 10% of the reflections were used for cross-validation analysis (39) and the behavior of R free used to monitor the refinement strategy. For the structure building and subsequent refinement data to 1.9 Å was used. Model building was carried out using programs O (40) and Turbo and refinement using CNS. Refinement included simulated annealing with torsion angle dynamics, anisotropic scaling, energy minimization, individual isotropic B-factor refinement and bulk-solvent correction against the maximum-likelihood target.
The structure refinement proceeded well until the later stages when it became clear that some parts of the structure (loops primarily) were poorly fitted. A reinspection of the data frames and reindexing displayed a larger unit cell to be the correct unit cell for this structure with a volume four times the size of the initial cell. This cell was not identified in the first instance due to weak diffraction for the additional reflections and could only be seen fully using the synchrotron source. After reprocessing of the data molecular replacement was carried out using co-ordinates of the refined AhpD trimer within CNS. The cross rotation function produced three distinct peaks and the translation functions identified the positions for three further AhpD trimers. The trimers are related by translation only. Following molecular replacement, refinement of the four independent trimers was carried out using CNS, with a similar protocol to that described above. As the starting trimer was already reasonably well refined in the smaller cell, at this point use of the non-crystallographic symmetry (NCS) constraints or restraints did not lead to improvement of the model and therefore the refinement was continued without NCS.
Refitting of the previously poorly fitting regions of the protein showed significant improvement as the refinement proceeded. During the final stages of the refinement well-defined residual electron density peaks in difference Fourier maps were assigned as solvent water molecules and included in the model. At the end of the refinement four residues were omitted from the model due to a lack of electron density in these regions (residues 61 from chain B and E, and residue 99 from chain G and L) and no residual electron density was unaccounted for. Root mean square deviations between the trimer comprising protein chains ABC and the other three protein trimers is 0.58Å (ABC/DEF), 1.12Å (ABC/GHI) and 0.91Å (ABC/JKL). Higher R factor values reflect the non-crystallographic symmetry that gave rise to systematically weaker reflections that were not clearly detectable until the crystals were diffracted by a stronger X-ray source (synchrotron radiation). These weaker reflections are associated with the larger unit cell. It has been recently noted that these types of structures do not refine to give low R factors (41) . While this paper was under review, another report on the AhpD structure was published in which the protein was crystallized under different conditions in a different crystal form (42) . Comparison of the two structures shows that the root mean square deviation ( r.m.s.d) for the main chain atoms is 0.5 Å, providing independent confirmation of the validity of both structures. Refinement of the structure was completed with 12 protein molecules in the crystallographic asymmetric unit. Diffraction data for the correct C2 data is shown in Table 2 and the final refinement parameters in Table 3 . 
Results
Overall structure -Electron density maps calculated with solvent-flattened MAD phases revealed that the protein is built entirely of α-helices. These maps were used both for tracing the C α chains and for the initial side chain assignments that were assisted by locating the positions of the Se atoms in the asymmetric unit. In contrast to the proposed homodimeric composition of AhpD suggested by analogy to its functional analogs and by gel-filtration data (24), the crystal structure showed that AhpD exists as a trimer (Fig. 1A) . The final refined model contains 12 subunits (four trimers), labeled A to L, with residues 4A-175A, 3B-175B, 3C-170C, etc. making a total of ~2100 residues (Table 3) . Data collection and model statistics are given in Tables 1, 2 Fig. 2 . Each of the subunits in the trimer ABC was built independently and subsequently the initial models for the other three trimers were generated from the ABC trimer by applying local symmetry matrixes. Further, each of the subunits was manually adjusted and refined independently.
For the purpose of this manuscript we will be referring only to trimer ABC in the figures and discussion.
The B-factors within the trimer indicate that the ends of the protein chains, particularly the N-terminus, and the solvent exposed loops that connect the helices have the highest temperature factors. These are the structural elements that would normally be expected to have the highest mobility.
AhpD forms a novel fold -A single subunit of AhpD is built of eight helices that fold in a pseudo-symmetrical topology (Fig. 3) with the core of the protein built of four central helices (α3, α4, α6, α7) flanked by two long helices (α5 and α8) on either side. A helixturn-helix motif of the N-terminal residues 3-27 (α1 and α2) forms the top of the double figure of eight-like fold while the corresponding residues (92 114) on the other side of the central region are less structured with only one 3 10 and one alpha helical turn. Some of the residues facing the core of the protein in this region of the molecule are involved in intersubunit interactions, while other residues in the same region are more flexible and solvent exposed. The structure was compared against all the structures in the PDB (September 2001) using the algorithm GRATH (45) and representatives from the CATH database (46) . The GRATH algorithm ranks all the pairwise comparisons using an optimized scoring function, and similar folds are found in the top 10 matches. For AhpD no global, significant structural match was found to any protein already in the PDB. Within the trimer, intermonomer interactions mostly involve the two long helices α5 and α8 such that, for example, helix α5 of subunit A interacts with helix α8 of subunit C on one side while helix terminal part of α7A -the helix that bears the active site residues. In this area, the two subunits A and C are also held together by a salt bridge between Asp97A and Arg148C. In addition, helix α2 also contributes to this interface: specifically, there is a hydrogen bond between Asp16C (α2) and nitrogen atoms of the backbone residues 105A and 106A.
The active site -The catalytically active residues Cys130 and Cys133 are located at the N-terminal end of helix α7, with Cys130 bordering on the central cavity of the trimer.
Structurally the Cys-Ser-His-Cys motif of AhpD resembles that of the thioredoxin family of proteins in which the two active site Cys residues are similarly located towards the Nterminus of the helix. However, in thioredoxin the helix is part of a βαβ structure with adjacent parallel strands, and the Asp implicated as the catalytically relevant acid-base residue is located on one of the β-strands. In AhpD, which is an all-helical molecule, no β-strands are involved in formation of the active site; however, the position that would spatially coincide with the location of aspartate carboxylate group is occupied by the imidazole ring of His137 (Fig. 4) .
The active sites appear to be structurally independent as all of the residues surrounding the two cysteines belong to the same subunit. However, it is possible that the individual subunits are unstable and that intersubunit interactions preserve the active site fold of the individual monomers. Although Cys130 is located at the edge of the central cavity, the distance between the closest Cys residues of neighboring subunits is ~15 Å (Fig. 3) , which clearly excludes the possibility of intersubunit disulfide bond formation and further suggests that the active sites function independently.
Proposed reaction mechanism -A cysteine residue in alkylhydroperoxidase (or peroxiredoxin) enzymes generally reacts with a hydroperoxide to give a sulfenic acid and the reduced hydroxy product. The sulfenic acid then reacts with a second sulfhydryl to give a disulfide bond. This second sulfhydryl is usually that of another cysteine residue in the same polypeptide or in a second subunit within an oligomeric complex, although it can also be provided by a small thiol molecule.
In AhpD from M. tuberculosis, each of the three subunits in the trimer has two cysteine residues, Cys130 and Cys133. The thiol group of Cys130, which borders the central cavity, is 3.5 Å from that of Cys133. The geometrical disposition of these cysteine sulfhydryls, despite the absence of sequence similarity with the peroxiredoxins, suggests that a related mechanism involving the two cysteine residues is responsible for the reduction of alkylhydroperoxides by AhpD. As the protein was crystallized in the presence of dithiothreitol, which is able to reduce the enzyme (24) , no disulfide bond is present in the enzyme. However, the relative orientation of the Cys130 and Cys133 thiol groups and the distance of 3.5 Å between them are clearly suitable for the formation of a disulfide bond between the two cysteines in the oxidized protein.
Mutagenesis studies have shown that mutation of Cys133 to a serine residue completely suppresses the alkylhydroperoxidase activity of the enzyme supported by the S.typhymurium AhpF redox partner, whereas similar mutation of Cys130 leaves a low residual activity (24) . This suggests, but does not prove, that Cys133 is the residue converted to a sulfenic acid by reaction with alkylhydroperoxidase substrates. Two histidine residues appear poised to facilitate the catalytic process. The nitrogen of His132 is 4.7 Å from the sulfur of Cys130 and 3.7 Å from that of Cys133 and thus could serve as a base for deprotonation of either cysteine.
The second histidine is His137, the nitrogen of which is 5.1 Å from the sulfur of Cys133 and 8.3 Å from that of Cys130. His137 is too far from Cys130 to interact productively with it, but it can readily interact with the sulfhydryl of Cys133 through an intervening water molecule that is located 3.3 Å from the sulfur atom of that residue and 2.5 Å from the nitrogen of His137. Furthermore, the N δ -H hydrogen of His137 is hydrogen bonded to Glu118, which is located 2.6 Å from the histidine nitrogen. This hydrogen bonding interaction should markedly increase the basicity of His137, as protonation of the N ε nitrogen of the histidine could be coupled to transfer of the N δ -H proton to the glutamic acid carboxylate group.
Another interesting observation is that the relation of His137 to Cys133 is similar to that between the catalytic aspartate and the cysteine in thioredoxins, in which the aspartate assists in deprotonation of the cysteine via the relay action of an intervening water molecule (47) .
Furthermore, spacing of the cysteines by two intervening residues is the same as that found in the thioredoxins (48) . We therefore propose that deprotonation of Cys133 facilitated by His137 leads to nucleophilic attack of the cysteine thiolate on the peroxide to give the sulfenic acid intermediate (Fig. 5) . Hydrogen bonding of the incipient thiolate with the amide hydrogen of Asn82 may assist its formation, as the amide nitrogen of Asn82 is only 3.4 Å away from the cysteine sulfhydryl group. Furthermore, His137 is so positioned that the proton transferred to it from the cysteine can be used to protonate the alkoxy anion that is formed as the hydroperoxide oxygen-oxygen bond is broken by attack of Cys133.
The second step of the catalytic cycle, formation of the disulfide bond between Cys133 and Cys130 with elimination of the sulfenic hydroxyl group as a water molecule, is likely to be triggered by deprotonation of Cys130 by His132, although a small movement of the residues towards each other would be necessary due to the distance of 4.7 Å between the nitrogen and sulfur atom. The incipient Cys130 thiolate anion would receive some stabilization from hydrogen bonding with the backbone nitrogen of Arg86, which is 3.5 Å from the cysteine sulfur atom. Attack of the cysteine thiolate on the sulfenic acid would give a Cys130-Cys133 disulfide bond. The proton transferred to His132 in this reaction step could be used to protonate the sulfenic hydroxyl group, facilitating its elimination as a water molecule, or could be retained to facilitate the disulfide cleavage reaction in the final step of the catalytic cycle. This final step involves reaction with a thiol-disulfide exchange protein that can be replaced in catalytic assays by the AhpF protein of S. typhimurium (24) .
Putative substrate binding site -The molecular surface of AhpD exhibits a very polar character, as shown by its calculated electrostatic potential. The central cavity is particularly positively charged and filled with water molecules and is therefore an unlikely binding site for the lipophilic compounds that were shown to be substrates for AhpD (24) . In addition to the central cavity of the cloverleaf trimeric structure there is a shallow hydrophobic grove associated with each of the subunits that extends from the outer, solvent-exposed edge to the active site cysteine residues. We propose that this groove is the binding site for alkylhydroperoxide substrates (Fig. 6 ). This binding site is formed by the aliphatic sidechains of the residues Ile77 and Met78 from helix α5, Met104, Ile106 and Ile107 from the connecting loop leading to helix α6, and Phe117 from the helix α6. As already mentioned, 
Discussion
The crystal structure of AhpD from M. tuberculosis together with mutagenesis data allows us to identify some of the catalytic residues and to describe a reaction mechanism for the alkylhydroperoxidase activity of this enzyme. Analysis of the proteins now known to have sequence identity with the M. tuberculosis AhpD indicates that the catalytic motif is largely preserved (26) (27) (28) (29) . This catalytic motif consists of two cysteines separated by two amino acid residues. The two spacer residues differ, being Ser-His in the mycobacterial proteins, Gly-Met in the Brucella melitensis and Streptomyces proteins, and His-Phe in the Ralstonia solanacearum protein. Thus, the equivalent of His132 is not present in some of the proteins and its catalytic role, if any, would have to be played by alternative residues.
However, the equivalent of His137 is conserved in all of the proteins, as is a carboxylate group equivalent to Glu118. It is therefore likely that the basic mechanism proposed for the activation of Cys133 is preserved in this new and growing family of proteins.
The two cysteine residues in AhpD more closely resemble the cysteines in thioredoxin than those in the peroxiredoxin family of enzymes, although apart from the spacing of the two cysteines there is little sequence identity between AhpD and the thioredoxins. The catalytic cysteines in the AhpC proteins are located at opposite ends of the polypeptide (49), whether their catalytic action involves disulfide bond formation within the same polypeptide (50) or between two polypeptides in an oligomeric structure (51) . In AhpD, the cysteine residues of one subunit are at least 15 Å from those of the adjacent subunit and are therefore clearly too far apart for intersubunit disulfide bond in the absence of a massive conformational change. On the other hand, as in the thioredoxins, the disulfide pair within a single AhpD chain is optimally placed for intramolecular disulfide bond formation.
A further resonance with the structure of the thioredoxins is provided by the mechanism of activation of Cys133 in AhpD. In the thioredoxins, a carboxylate oxygen is located approximately 6 Å from the sulfur of one of the two catalytic cysteines (47) . However, through an intervening water molecule, it is proposed that the carboxylic acid serves as the base that deprotonates the cysteine residue. Comparison of the location in protein space of the carboxylic acid in the thioredoxins shows that the corresponding site is occupied in AhpD by a histidine, specifically His137. This histidine is activated by hydrogen bonding to Glu118, and a water molecule provides a bridge between the carboxylate oxygen atoms and the thiolate of Cys133. Thus, a mechanism for deprotonation of the cysteine can be written that closely resembles that of thioredoxin, except that the carboxylate is even further from the cysteine proton and its function as an acid-base catalyst is relayed through a histidine and a water molecule.
Completion of the catalytic cycle requires reduction of the disulfide bond that is formed between Cys130 and Cys133. In our earlier catalytic studies, reduction of the double bond was achieved using either dithiothreitol or the S. typhimurium AhpF as a surrogate reducing partner (24) . In each instance, a disulfide exchange reaction is responsible for regeneration of the reduced form of AhpD. During review of this paper, an endogenous system was reported in M. tuberculosis that is able to efficiently reduce AhpD (42) . This system consists of SucB, a dihydrolipoamide-containing protein that undergoes a disulfide exchange reaction with AhpF, and dihydrolipoamide dehydrogenase, which regenerates the dihydrolipoamide cofactor of SucB. Resolution (Å) 500 -1.9
Total number of reflections 1263412 Total atoms = 15307
Number of solvent water molecules 860
Resolution used in refinement 500 -1.9 Å R cryst 24. % residues in most favoured regions 92.6 % residues in additionally allowed regions 7.2 a Calculated using PROCHECK (52).
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